Taken together, our data suggest that KLF4 is an essential regulator in cisplatin-induced apoptosis, and the miR-32-5p-KLF4-BIK signalling axis plays an important role in cisplatin sensitivity of prostate cancer. This evidence concerns the gene KLF4 and prostate carcinoma.